Physician profile
Amy Barton
NPI 1063713436
$2,259.20
in general payments reported to CMS, 2019-2025
16 companies · $764 in 2025
The $764 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $381 · 2023: $454 · 2024: $541 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $364.61 | 2022-2025 | Watchman Flx, Watchman Access System |
| Neurocrine Biosciences, INC. | $347.88 | 2023-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $244.34 | 2024-2025 | Austedo Xr, Austedo Xr |
| Genzyme Corporation | $147.71 | 2024 | |
| Pulmonx Corporation | $139.78 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Regeneron Healthcare Solutions, INC. | $118.86 | 2025 | Dupixent |
| Pharmaessentia USA Corporation | $118.86 | 2025 | Besremi |
| Bayer Healthcare Pharmaceuticals INC. | $118.76 | 2021 | |
| Genentech USA, INC. | $92.88 | 2022 | |
| Grt US Holding, INC. | $88.55 | 2022 | |
| Abbvie INC. | $88.53 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $82.52 | 2023 | Lokelma |
| Horizon Therapeutics Plc | $78.41 | 2023 | Uplizna |
| Akebia Therapeutics INC | $78.33 | 2023 | Auryxia |
| Alnylam Pharmaceuticals INC. | $77.78 | 2024 | Oxlumo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $71.40 | 2024 | Venaseal, Closurefast |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.